Highlights
NASDAQ: PRTO       Proteon Thera Com ST
Last Price Today's Change   Day's Range   Trading Volume
0.835   0.00 (0.00%)  0.00 - 0.00  0

Overview

 
Avg Volume (4 weeks):2,179,636
4 Weeks Range:0.36 - 0.955
4 Weeks Price Volatility (%):
87.43%
52 Weeks Range:0.22 - 3.94
52 Weeks Price Volatility (%):
21.19%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Proteon Therapeutics Inc. is an early-stage biopharmaceutical company engaged in the development of elastases to treat the growing medical needs of renal and vascular disease patients. The Company's product candidate, vonapanitase, is a recombinant human elastase, developing to reduce vascular access failure in patients with chronic kidney disease undergoing or preparing for hemodialysis, a lifesaving treatment that cannot be conducted without a functioning vascular access. It competes with companies developing vascular access technologies, including BioConnect Systems, Caymus Medical, Phraxis, CreatiVasc, and TVA Medical, among others.

  Be the first to like this.
 


 

1843  6298  540  225 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 VXX 14.24+0.75 
 EEM 44.60-0.36 
 SPY 328.77-2.95 
 INTC 68.47+5.15 
 AMD 50.35-1.36 
 CHK 0.558-0.015 
 F 9.00-0.14 
 NIO 4.66-0.26 
 AVP 5.60-0.05 
 GE 11.71-0.06 
Partners & Brokers